You are here

rhinosinusitis

MedStar and Georgetown scientists to conduct acute rhinosinusitis trial

Clinical Trials Arena

Thu, 08/11/22 - 10:40 am

clinical trials

Georgetown University

AnaptysBio's etokimab provides more disappointing results, raising questions about compound's future

Endpoints

Mon, 08/10/20 - 11:01 am

clinical trials

GSK's asthma biologic Nucala is one step closer to approval in key chronic rhinosinusitis population

Endpoints

Fri, 04/3/20 - 11:12 am

clinical trials

Sanofi and Regeneron's Dupixent scores 3rd FDA approval in sinusitis with nasal polyps

Fierce Pharma

Wed, 06/26/19 - 05:21 pm

Regeneron, Sanofi talks up potential blockbuster franchise as Dupixent sweeps in rhinosinusitis PhIII

Endpoints

Tue, 10/16/18 - 11:44 am